AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
May 23, 2025
35599_dirs_2025-05-23_af221a4e-bbbb-4d06-b2ee-702270a5d163.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-05-22
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-22 | Common shares | M | 8220 | $5.10 | Acquired | 158520 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | Stock Options | $5.10 | M | 8220 | Disposed | 2027-06-27 | Options (8220) | Direct |
Footnotes
F1: Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20